You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

 

Online download statistics by month:

Online download statistics by month: January 2024 to August 2025

AbstractFullPdf
Jan 2024706708214
Feb 2024356359214
Mar 2024366373379
Apr 2024245246140
May 202417718091
Jun 202418819397
Jul 202419819891
Aug 2024158158125
Sep 2024182182335
Oct 2024155156210
Nov 202416917074
Dec 202418718974
Jan 202524224277
Feb 202541441485
Mar 202517717784
Apr 202524324485
May 202515715887
Jun 202511711743
Jul 2025110
Aug 2025110
Total443944662505